Company profile
Septerna, Inc.
NASDAQ:SEPNBiotechnology: Pharmaceutical Preparations
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT07433179 | phase1 | recruiting | 2026-03-04 | 2027-02-01 | Septerna, Inc. | A Study to Evaluate Single and Multiple Doses of SEP-479 in Healthy Adult Participants |
| NCT07069036 | phase1 | completed | 2025-07-15 | 2025-12-18 | Septerna, Inc. | A Study to Evaluate Single and Multiple Doses of SEP-631 in Healthy Adult Volunteers |
FDA applications (0)
No records yet.